Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 47, Issue 2, 1999, Pages 133-138

  Lipp, Ralph ^a   Müller Fahrnow, Anke ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Estradiol; Gestodene; Transdermal drug delivery system; X ray crystallography

Indexed keywords

ESTRADIOL; GESTODENE;

ARTICLE; CRYSTALLIZATION; DRUG STORAGE; POLARIZATION MICROSCOPY; TRANSDERMAL DRUG ADMINISTRATION; X RAY CRYSTALLOGRAPHY;

ADMINISTRATION, CUTANEOUS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ESTRADIOL; NORPREGNENES;

EID: 0344097395     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00055-1     Document Type: Article

References (15)

1. Y.W. Chien, Systemic delivery of pharmacologically active molecules across the skin, in: R.L. Juliano (Ed.), Targeted Drug Delivery, Springer-Verlag, Berlin, Heidelberg, New York, 1991, pp. 181-230.
2. M.C. Musolf, Pressure-sensitive adhesives for transdermal applications, in: Y.W. Chien (Ed.), Transdermal Controlled Systemic Medications, Marcel Dekker, New York, 1987, pp 104-112.
3. B.W. Barry, Dermatological Formulations: Percutaneous Absorption, In: J. Swarbrick (Ed.) Drugs and the pharmaceutical sciences, Marcel Dekker, New York, 1983, pp. 160-204.
4. J. Yu, T. Chien, Y.W. Chien, Transdermal dual-controlled delivery of testosterone and estradiol: (I) impact of system design, Drug Dev. Ind. Pharm. 17 (1991) 1883-1904.
5. X. Ma, J. Taw, C.M. Chiang, Control of drug crystallization in transdermal matrix systems, Int. J. Pharm. 142 (1996) 115-119.
6. F.J.E. Stefano, F.I. Biali, A.F. Scasso, Crystallization in NETA-17ß-E2 transdermal patches, Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 24 (1997) 703.
7. R. Lipp, G. Heimann, Statistical approach to optimization of drying conditions of a transdermal delivery system, Drug Dev. Ind. Pharm. 22 (1996) 343-348.
8. SHELXTL + , Version 5, Siemens Analytical Instruments, Inc.
9. B. Busetta, M. Hospital, Structure cristalline et moleculaire de ĺ'oestradiol hemihydrate, Acta Cryst. B28 (1972) 560-567.
10. E. Eckle, G.-A. Hoyer, H. Hofmeister, H. Laurent, D. Schomburg, R. Wiechert, Die Kristall- und Molekülstruktur von Gestoden, Liebigs Ann. Chem. (1988) 199-202.
11. V.J. van Geerestein, A.J.M. Duisenberg, M.H.G. Duits, J.A. Kanters, J. Kroon, Structure of modifications (I) and (II) 13-ethyl-17β-hydroxy-18,19-dinor-17α-pregna-4,15-dien-20-yn-3-one (gestodene), Acta Cryst. C43 (1987) 2402-2405.
12. B. Busetta, Y. Barrans, G. Precigoux, M. Hospital, 1,3,5,(10)oestratrien-3,17α-diol, Acta Cryst. B32 (1976) 1290-1292.
13. W.L. Duax, Crystal structure of the estradiol urea complex, Acta Cryst. B28 (1972) 1864-1866.
14. M. Bock, G. Depke, U. Egner, A. Müller-Fahrnow, G. Winter, Detection and characterization of polymorphic modifications of the anxiolytic drug ABECARNIL, Tetrahedron 50 (1994) 13125-13134.
15. G.R. Lloyd, D.Q.M. Craig, A. Smith, An investigation into the melting behavior of binary mixes and solid dispersions of paracetamol and PEG 4000, J. Pharm. Sci. 86 (1997) 991-996.